STAND. COM. REP. NO. 1320-18

Honolulu, Hawaii

, 2018

RE: S.B. No. 2811

S.D. 1

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sir:

Your Committee on Health & Human Services, to which was referred S.B. No. 2811, S.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"

begs leave to report as follows:

The purpose of this measure is to update Chapter 329, Hawaii Revised Statutes (HRS), the Uniform Controlled Substances Act, to be consistent with federal law, including allowing properly registered practitioners to prescribe drugs, including buprenorphine and naloxone, to patients undergoing medically managed withdrawal, provided that the practitioner complies with specific requirements.

The Department of Public Safety, Department of Health, Hawaii Substance Abuse Coalition, Life Foundation, The CHOW Project, The Drug Policy Forum of Hawaii, and Oahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i supported this measure.

Your Committee has amended this measure by:

(1) Inserting language which further updates Schedules I and II of the Uniform Controlled Substances Act, to be consistent with amendments to the federal Controlled Substances Act, as required under Section 329-11, HRS; and

(2) Changing its effective date to July 1, 3000, to encourage further discussion.

As affirmed by the record of votes of the members of your Committee on Health & Human Services that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2811, S.D. 1, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2811, S.D. 1, H.D. 1, and be referred to your Committee on Judiciary.

Respectfully submitted on behalf of the members of the Committee on Health & Human Services,

____________________________

JOHN M. MIZUNO, Chair